Songbin He, Tianliang Liu, Yingyi Zhang. "ADRB2-driven immunosuppression as a novel prognostic indicator and therapeutic avenue following neoadjuvant treatment in colorectal cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15533